What’s Included

• One Report Covering 30 Countries
• Sizing for 20 Important IVD Market Segments
• Segments Estimated for Each Country
• Forecasts to 2028 for Each Segment
• Updated Quarterly (4 updates annually) to Reflect Market Changes
• Over 2800 Data Points

About the Report

With over two decades of experience in publishing in vitro diagnostic (IVD) market research, Kalorama Information understands the importance of global coverage and the need for more detailed geographic analysis. While regional coverage is valuable, it often falls short of providing a complete picture. This is why we are offering a unique approach focused on country-level research and analysis in our 30 Country In Vitro Diagnostics (IVD) Market Atlas, 2024.

This quarterly updated report provides a detailed analysis of the major IVD segments forecasted for five years, covering 30 countries. To replicate the depth of data found in the IVD Market Atlas, one would need to purchase numerous individual market research studies from other companies. This report aligns with Kalorama’s expert global estimates in our annual Worldwide Market for In Vitro Diagnostics, offering segmented market analysis for 30 important country markets and 20 key test segments. Global country market coverage includes:

• Australia
• Austria
• Belgium
• Brazil
• Canada
• Chile
• China
• Egypt
• France
• Germany
• India
• Indonesia
• Italy
• Japan
• Mexico
• Netherlands
• Poland
• Romania
• Russia
• Saudi Arabia
• South Africa
• South Korea
• Spain
• Sweden
• Switzerland
• Turkey
• United Arab Emirates
• United Kingdom
• United States
• Vietnam

While other market researchers may sell separate reports for each country, Kalorama's approach is to provide comprehensive and timely information in one report, aligning with our mission to keep companies informed with relevant references. The IVD Market Atlas reflects this commitment. For each country, the report provides an overall IVD market estimate, as well as detailed breakdowns of the most important market segments, including:

• General Chemistries
• Critical Care (core lab)
• Hematology
• Coagulation PT/Routine
• Immunoassays – Micro
• Immunoassays - Non-Micro
• Blood Bank Screening - Immunos
• Microbiology – ID/AST
• Molecular Respiratory
• Molecular Bloodstream/HAI
• Molecular HIV & Hepatitis
• Molecular - Other¹ 
• POC Glucose (all)
• POC Critical Care
• POC Infectious Disease (all)
• POC Pregnancy & Fertility
• POC Fecal Occult
• Other POC
• Histology
• Other IVD

While these segments do not cover every possible segment, they represent the most important ones based on demand, size, and relevance.

The report is updated every quarter to reflect market changes. Factors such as COVID-19, international developments, M&A activity, new products, point-of-care trends, and regulatory changes have increased the pace of change in the IVD market. While significant market shifts may not occur every quarter, the report ensures that you have the most up-to-date data for your business planning.

Subscribers will receive quarterly updates through our Knowledge Center product.